Cargando…

CRISPR activation screening in a mouse model for drivers of hepatocellular carcinoma growth and metastasis

Hepatocellular carcinoma (HCC) remains a major cause of cancer-related mortality worldwide. Here we described a genome-wide screen by CRISPR activation (CRISPRa) library in vivo for drivers of HCC growth and metastasis. Pathological results showed the cell population formed highly metastatic tumors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Bei, Ren, Zhiyao, Zheng, Hongmei, Lin, Meilan, Chen, Guobing, Luo, Oscar Junhong, Zhu, Guodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947337/ https://www.ncbi.nlm.nih.gov/pubmed/36843840 http://dx.doi.org/10.1016/j.isci.2023.106099

Ejemplares similares

CRISPR and transposon in vivo screens for cancer drivers and therapeutic targets
por: Noorani, Imran, et al.
Publicado: (2020)

Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth
por: Wang, Yu, et al.
Publicado: (2019)

Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis
por: Zhang, Jingjing, et al.
Publicado: (2022)

Global analysis of HLA-A2 restricted MAGE-A3 tumor antigen epitopes and corresponding TCRs in non-small cell lung cancer
por: Zhang, Bei, et al.
Publicado: (2023)

Rare Gingival Metastasis by Hepatocellular Carcinoma
por: Xue, Li-Jun, et al.
Publicado: (2017)

Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening
por: Kiessling, Michael K., et al.
Publicado: (2016)

Construction of a Comprehensive Multiomics Map of Hepatocellular Carcinoma and Screening of Possible Driver Genes
por: Liu, Ziyu, et al.
Publicado: (2020)

Genome-scale CRISPR-Cas9 knockout screening in hepatocellular carcinoma with lenvatinib resistance
por: Lu, Yonggang, et al.
Publicado: (2021)

Screening therapeutic targets of ribavirin in hepatocellular carcinoma
por: Xu, Chen, et al.
Publicado: (2018)

In vitro CRISPR screening uncovers CRTC3 as a regulator of IFN-γ-induced ferroptosis of hepatocellular carcinoma
por: Li, Li, et al.
Publicado: (2023)

A CRISPR-Cas9 library screening identifies CARM1 as a critical inhibitor of ferroptosis in hepatocellular carcinoma cells
por: Cheng, Yiming, et al.
Publicado: (2023)

Phospholipid Phosphatase 4 as a Driver of Malignant Glioma and Pancreatic Adenocarcinoma
por: Tian, Wenxiu, et al.
Publicado: (2021)

Correction: Genome-scale CRISPR-Cas9 knockout screening in hepatocellular carcinoma with lenvatinib resistance
por: Lu, Yonggang, et al.
Publicado: (2022)

Bile acids as drivers and biomarkers of hepatocellular carcinoma
por: Colosimo, Santo, et al.
Publicado: (2022)

Cellular Senescence in Hepatocellular Carcinoma: The Passenger or the Driver?
por: Cai, Xiurong, et al.
Publicado: (2022)

Genome-scale CRISPR screening in a single mouse liver
por: Keys, Heather R., et al.
Publicado: (2022)

Knockdown of KIAA1199 attenuates growth and metastasis of hepatocellular carcinoma
por: Liu, Jingmei, et al.
Publicado: (2018)

Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy
por: Ding, Xiao-Xiao, et al.
Publicado: (2017)

Effect of CMB Carrying PTX and CRISPR/Cas9 on Endometrial Cancer Naked Mouse Model
por: Cai, Junhong, et al.
Publicado: (2022)

Immunological risk factors for sepsis-associated delirium and mortality in ICU patients
por: Lei, Wen, et al.
Publicado: (2022)

MYC associated zinc finger protein promotes the invasion and metastasis of hepatocellular carcinoma by inducing epithelial mesenchymal transition
por: Luo, Wei, et al.
Publicado: (2016)

CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma
por: Suemura, Shigeki, et al.
Publicado: (2019)

CRISPR screens uncover protective effect of PSTK as a regulator of chemotherapy-induced ferroptosis in hepatocellular carcinoma
por: Chen, Yiran, et al.
Publicado: (2022)

Identification of Driver Genes Regulating the T-Cell–Infiltrating Levels in Hepatocellular Carcinoma
por: Cai, Yi, et al.
Publicado: (2020)

Isolated metastasis of hepatocellular carcinoma in the right ventricle
por: Zhang, Xin-tong, et al.
Publicado: (2019)

High expression of DHX9 promotes the growth and metastasis of hepatocellular carcinoma
por: Shi, Feng, et al.
Publicado: (2021)

NOL12 as an Oncogenic Biomarker Promotes Hepatocellular Carcinoma Growth and Metastasis
por: Huang, Jianfeng, et al.
Publicado: (2022)

37. IN VIVO FUNCTIONAL GENOMIC SCREEN TO IDENTIFY NOVEL DRIVERS OF LUNG-TO-BRAIN METASTASIS
por: Aghaei, Nikoo, et al.
Publicado: (2020)

Identification of HLA-A2 restricted CD8(+) T cell epitopes in SARS-CoV-2 structural proteins
por: Deng, Jieping, et al.
Publicado: (2021)

Organ microenvironment affects growth and metastasis of hepatocellular carcinoma via the TGF-β/Smad pathway in mice
por: LI, GUOCAI, et al.
Publicado: (2013)

Knockout of Hepatocyte Growth Factor by CRISPR/Cas9 System Induces Apoptosis in Hepatocellular Carcinoma Cells
por: Lee, Han Ki, et al.
Publicado: (2021)

In Vivo Genome-Wide CRISPR Activation Screening Identifies Functionally Important Long Noncoding RNAs in Hepatocellular Carcinoma
por: Wong, Lok-Sze, et al.
Publicado: (2022)

Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC
por: Wei, Lai, et al.
Publicado: (2019)

Genome-wide CRISPR Screening to Identify Drivers of TGF-β-Induced Liver Fibrosis in Human Hepatic Stellate Cells
por: Yu, Shan, et al.
Publicado: (2022)

The application of genome-wide CRISPR-Cas9 screens to dissect the molecular mechanisms of toxins
por: Wang, Bei, et al.
Publicado: (2022)

Targeting Oncoimmune Drivers of Cancer Metastasis
por: Kudo-Saito, Chie, et al.
Publicado: (2021)

Downregulation of ZEB2-AS1 decreased tumor growth and metastasis in hepatocellular carcinoma
por: Lan, Tian, et al.
Publicado: (2016)

Knockout of the Nogo-B Gene Attenuates Tumor Growth and Metastasis in Hepatocellular Carcinoma()
por: Zhu, Bo, et al.
Publicado: (2017)

SWELL1 promotes cell growth and metastasis of hepatocellular carcinoma in vitro and in vivo
por: Lu, Panpan, et al.
Publicado: (2019)

RBCK1 promotes hepatocellular carcinoma metastasis and growth by stabilizing RNF31
por: Chen, Xijun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2c65q3fo0d708rkj71ccbani2b